Company Filing History:
Years Active: 1989-1993
Title: Innovations in Malignant Disease Treatment by Bruce Grossie, Jr.
Introduction
Bruce Grossie, Jr. is an accomplished inventor based in Houston, TX. He has made significant contributions to the field of medical nutrition, particularly in the treatment of malignant diseases. With a total of four patents to his name, Grossie's work focuses on innovative formulations that enhance patient care.
Latest Patents
Grossie's latest patents include methods for the treatment of malignant disease in patients using total parenteral nutrition formulations. These formulations incorporate essential amino acids combined with either arginine or ornithine. They are designed for the detection of recurrent malignant disease in patients. The formulations stimulate tumor-specific polyamine production more effectively than non-tumor related polyamine production. Additionally, they promote an increase in red blood cell putrescine levels in tumor-bearing rats, while nontumor-bearing rats do not exhibit similar reactions. The patents also disclose methods for making and administering these formulations, as well as their use in preventing DFMO-induced toxicity.
Career Highlights
Grossie is affiliated with the University of Texas System, where he continues to advance research in medical nutrition. His innovative approaches have the potential to significantly impact the treatment of malignant diseases, improving patient outcomes.
Collaborations
He has collaborated with notable colleagues, including Jaffer Ajani and Kenji Nishioka, to further enhance the effectiveness of his research and patents.
Conclusion
Bruce Grossie, Jr. is a pioneering inventor whose work in total parenteral nutrition formulations is paving the way for improved treatments for malignant diseases. His contributions are vital to the ongoing advancements in medical nutrition and patient care.